GLOBAL MEDICAL REIT INC (GMRE) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:GMRE • US37954A3032

36.63 USD
-0.08 (-0.22%)
At close: Feb 6, 2026
36.63 USD
0 (0%)
After Hours: 2/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall GMRE gets a fundamental rating of 2 out of 10. We evaluated GMRE against 124 industry peers in the Diversified REITs industry. GMRE may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, GMRE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • GMRE had positive earnings in the past year.
  • In the past year GMRE had a positive cash flow from operations.
  • Of the past 5 years GMRE 4 years were profitable.
  • Each year in the past 5 years GMRE had a positive operating cash flow.
GMRE Yearly Net Income VS EBIT VS OCF VS FCFGMRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

  • With a Return On Assets value of -0.26%, GMRE is not doing good in the industry: 62.10% of the companies in the same industry are doing better.
  • GMRE has a Return On Equity of -0.69%. This is in the lower half of the industry: GMRE underperforms 62.10% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.18%, GMRE is doing worse than 60.48% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for GMRE is in line with the industry average of 3.05%.
Industry RankSector Rank
ROA -0.26%
ROE -0.69%
ROIC 2.18%
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
GMRE Yearly ROA, ROE, ROICGMRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

  • In the last couple of years the Profit Margin of GMRE has declined.
  • The Operating Margin of GMRE (23.29%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of GMRE has declined.
  • The Profit Margin and Gross Margin are not available for GMRE so they could not be analyzed.
Industry RankSector Rank
OM 23.29%
PM (TTM) N/A
GM N/A
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
GMRE Yearly Profit, Operating, Gross MarginsGMRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GMRE is destroying value.
  • GMRE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GMRE has been increased compared to 5 years ago.
  • GMRE has a worse debt/assets ratio than last year.
GMRE Yearly Shares OutstandingGMRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GMRE Yearly Total Debt VS Total AssetsGMRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 0.18, we must say that GMRE is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.18, GMRE is doing worse than 67.74% of the companies in the same industry.
  • GMRE has a Debt/Equity ratio of 1.46. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.46, GMRE is in line with its industry, outperforming 43.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Altman-Z 0.18
ROIC/WACC0.35
WACC6.3%
GMRE Yearly LT Debt VS Equity VS FCFGMRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

  • GMRE has a Current Ratio of 0.33. This is a bad value and indicates that GMRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GMRE's Current ratio of 0.33 is on the low side compared to the rest of the industry. GMRE is outperformed by 84.68% of its industry peers.
  • GMRE has a Quick Ratio of 0.33. This is a bad value and indicates that GMRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.33, GMRE is doing worse than 83.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
GMRE Yearly Current Assets VS Current LiabilitesGMRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • GMRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 470.00%, which is quite impressive.
  • Measured over the past years, GMRE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.74% on average per year.
  • GMRE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.14%.
  • Measured over the past years, GMRE shows a quite strong growth in Revenue. The Revenue has been growing by 14.44% on average per year.
EPS 1Y (TTM)470%
EPS 3Y-40.51%
EPS 5Y-16.74%
EPS Q2Q%-86.67%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y6.19%
Revenue growth 5Y14.44%
Sales Q2Q%8.65%

3.2 Future

  • GMRE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -17.69% yearly.
  • Based on estimates for the next years, GMRE will show a small growth in Revenue. The Revenue will grow by 3.43% on average per year.
EPS Next Y39.4%
EPS Next 2Y8.31%
EPS Next 3Y26.83%
EPS Next 5Y-17.69%
Revenue Next Year5.73%
Revenue Next 2Y4.45%
Revenue Next 3Y4.16%
Revenue Next 5Y3.43%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GMRE Yearly Revenue VS EstimatesGMRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
GMRE Yearly EPS VS EstimatesGMRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 99.00, which means the current valuation is very expensive for GMRE.
  • Based on the Price/Earnings ratio, GMRE is valued a bit more expensive than the industry average as 60.48% of the companies are valued more cheaply.
  • The average S&P500 Price/Earnings ratio is at 27.92. GMRE is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 156.14, the valuation of GMRE can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as GMRE.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.78, GMRE is valued quite expensively.
Industry RankSector Rank
PE 99
Fwd PE 156.14
GMRE Price Earnings VS Forward Price EarningsGMRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GMRE is valued a bit cheaper than 68.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.19
GMRE Per share dataGMRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GMRE does not grow enough to justify the current Price/Earnings ratio.
  • GMRE's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.51
PEG (5Y)N/A
EPS Next 2Y8.31%
EPS Next 3Y26.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 8.17%, GMRE is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 6.82, GMRE pays a better dividend. On top of this GMRE pays more dividend than 83.87% of the companies listed in the same industry.
  • GMRE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 8.17%

5.2 History

  • The dividend of GMRE is nicely growing with an annual growth rate of 37.64%!
  • GMRE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of GMRE decreased in the last 3 years.
Dividend Growth(5Y)37.64%
Div Incr Years0
Div Non Decr Years2
GMRE Yearly Dividends per shareGMRE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • The earnings of GMRE are negative and hence is the payout ratio. GMRE will probably not be able to sustain this dividend level.
DP-1886.35%
EPS Next 2Y8.31%
EPS Next 3Y26.83%
GMRE Yearly Income VS Free CF VS DividendGMRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

GLOBAL MEDICAL REIT INC

NYSE:GMRE (2/6/2026, 8:04:00 PM)

After market: 36.63 0 (0%)

36.63

-0.08 (-0.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-04
Earnings (Next)03-03
Inst Owners71.79%
Inst Owner Change-3.13%
Ins Owners0.51%
Ins Owner Change0.51%
Market Cap491.21M
Revenue(TTM)144.97M
Net Income(TTM)-3.33M
Analysts80
Price Target41.67 (13.76%)
Short Float %5.39%
Short Ratio6.09
Dividend
Industry RankSector Rank
Dividend Yield 8.17%
Yearly Dividend4.96
Dividend Growth(5Y)37.64%
DP-1886.35%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-95.33%
Min EPS beat(2)-132.68%
Max EPS beat(2)-57.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-4.34%
Max Revenue beat(2)5.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-4.34%
Max Revenue beat(4)5.24%
Revenue beat(8)2
Avg Revenue beat(8)-2.13%
Revenue beat(12)2
Avg Revenue beat(12)-2.18%
Revenue beat(16)3
Avg Revenue beat(16)-1.81%
PT rev (1m)1.51%
PT rev (3m)-4.15%
EPS NQ rev (1m)95.02%
EPS NQ rev (3m)8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)20.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE 99
Fwd PE 156.14
P/S 3.39
P/FCF N/A
P/OCF 6.82
P/B 1.01
P/tB 1.15
EV/EBITDA 13.19
EPS(TTM)0.37
EY1.01%
EPS(NY)0.23
Fwd EY0.64%
FCF(TTM)-4.35
FCFYN/A
OCF(TTM)5.37
OCFY14.65%
SpS10.81
BVpS36.19
TBVpS31.98
PEG (NY)2.51
PEG (5Y)N/A
Graham Number17.36
Profitability
Industry RankSector Rank
ROA -0.26%
ROE -0.69%
ROCE 2.75%
ROIC 2.18%
ROICexc 2.19%
ROICexgc 2.32%
OM 23.29%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
ROICexc(3y)2.3%
ROICexc(5y)2.11%
ROICexgc(3y)2.52%
ROICexgc(5y)2.3%
ROCE(3y)2.9%
ROCE(5y)2.66%
ROICexgc growth 3Y-3.14%
ROICexgc growth 5Y-2.71%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y-2.82%
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Debt/EBITDA 7.84
Cap/Depr 229.77%
Cap/Sales 89.9%
Interest Coverage 1.16
Cash Conversion 79.54%
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z 0.18
F-Score3
WACC6.3%
ROIC/WACC0.35
Cap/Depr(3y)155.62%
Cap/Depr(5y)302.85%
Cap/Sales(3y)63.21%
Cap/Sales(5y)120.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)470%
EPS 3Y-40.51%
EPS 5Y-16.74%
EPS Q2Q%-86.67%
EPS Next Y39.4%
EPS Next 2Y8.31%
EPS Next 3Y26.83%
EPS Next 5Y-17.69%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y6.19%
Revenue growth 5Y14.44%
Sales Q2Q%8.65%
Revenue Next Year5.73%
Revenue Next 2Y4.45%
Revenue Next 3Y4.16%
Revenue Next 5Y3.43%
EBIT growth 1Y-3.06%
EBIT growth 3Y-3.87%
EBIT growth 5Y3.82%
EBIT Next Year173.9%
EBIT Next 3Y43.15%
EBIT Next 5Y31.78%
FCF growth 1Y-196.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.88%
OCF growth 3Y0.52%
OCF growth 5Y13.97%

GLOBAL MEDICAL REIT INC / GMRE FAQ

What is the ChartMill fundamental rating of GLOBAL MEDICAL REIT INC (GMRE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GMRE.


What is the valuation status of GLOBAL MEDICAL REIT INC (GMRE) stock?

ChartMill assigns a valuation rating of 1 / 10 to GLOBAL MEDICAL REIT INC (GMRE). This can be considered as Overvalued.


What is the profitability of GMRE stock?

GLOBAL MEDICAL REIT INC (GMRE) has a profitability rating of 2 / 10.


What is the earnings growth outlook for GLOBAL MEDICAL REIT INC?

The Earnings per Share (EPS) of GLOBAL MEDICAL REIT INC (GMRE) is expected to grow by 39.4% in the next year.


Can you provide the dividend sustainability for GMRE stock?

The dividend rating of GLOBAL MEDICAL REIT INC (GMRE) is 6 / 10 and the dividend payout ratio is -1886.35%.